ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HROW Harrow Inc

21.00
-0.34 (-1.59%)
27 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Harrow Inc NASDAQ:HROW NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.34 -1.59% 21.00 20.91 21.00 21.49 20.7521 21.34 496,005 21:58:54

Harrow to Present at Two Investor Conferences in May

15/05/2024 12:00pm

Business Wire


Harrow (NASDAQ:HROW)
Historical Stock Chart


From Apr 2024 to Jun 2024

Click Here for more Harrow Charts.

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following two investor conferences in May:

B. Riley Securities 24th Annual Institutional Investor Conference (Beverly Hilton Hotel, Beverly Hills, CA) Format: Fireside Chat (In-Person), followed by 1x1 Investor Meetings Date/Time: Wednesday, May 22, 2024, through Thursday, May 23, 2024

Craig-Hallum 21st Annual Institutional Investor Conference (Depot Renaissance Hotel, Minneapolis, MN) Format: 1x1 and Small Group Investor Meetings Date/Time: Wednesday, May 29, 2024

Investors interested in meeting with management during either conference should contact their B. Riley or Craig-Hallum representative to request a meeting. Neither event will be webcast.

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

Jamie Webb, Director of Communications and Investor Relations jwebb@harrowinc.com 615-733-4737

1 Year Harrow Chart

1 Year Harrow Chart

1 Month Harrow Chart

1 Month Harrow Chart